BrightEdge Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

BrightEdge Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Sep 3, 2025	Mercy BioAnalytics	$59.0M Series B	Paul Meister, Paul Meister, Rob Freelen	Avestria Ventures, Bruker, Hologic, iSelect Fund, Labcorp, Mindshift Capital, Perceptive Xontogeny Venture Fund, Portfolia
Sep 1, 2025	Predicta Biosciences	$23.0M Series A	Ann DeWitt	BlueStone Venture Partners, The Engine, Ulu Ventures, Binney Street Capital, Illumina Ventures, Lightchain Capital, Mass General Brigham Ventures, Myeloma Solutions Fund
May 8, 2024	Catena Biosciences	$2.4M Seed Extension	—	Caffeinated Capital, California Innovation Fund, Civilization Ventures, Freeflow Ventures, Sergey Jakimov, Pioneer Fund
Mar 1, 2023	Mercy BioAnalytics	$41.0M Series A	Paul Meister	Agent Capital, Cofounders Capital, Domain Associates, Leaps by Bayer, Longwood Fund, Novartis Venture Fund, Broadway Angels, Bruker, Hatteras Venture Partners, iSelect Fund, Labcorp, Sozo Ventures
Dec 1, 2021	Freenome	$300.0M Series D	Ellen Hukkelhoven, Peter Kolchinsky	Anzu Partners, Ameena El-Bibany, Vasudev Bailey, Artis Ventures (AV), Asset Management Ventures, Bain Capital Life Sciences, Cofounders Capital, Merck Global Health Innovation Fund, Polaris Partners, RA Capital, Section 32, Anne Wojcicki, Timothy A. Springer, Andreessen Horowitz, ArrowMark Partners, Byers Capital, Catalio Capital Management, Data Collective, Eventide Asset Management, Farallon Capital Management, Fidelity Management & Research Company, Google Ventures, HBM Healthcare Investments, Intermountain Ventures, Janus Henderson Investors, Kaiser Permanente, Logos Capital, Novartis, Polaris Partners, Pura Vida Investments, Ridgeback Capital Investments, Thomas Schinecker, Rock Springs Capital, Sands Capital, Soleus Capital, Suvretta Capital Management, T. Rowe Price Associates
Nov 25, 2021	Lunit	$61.0M Other Equity	—	Casdin Capital, Guardant Health, HealthQuest Capital, NSG Ventures, Tybourne Capital Management